Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Carlos Rocco"'
Autor:
Judith Yancoski, Claudio Cantisano, Carlos Rocco, Silvia Danielian, María Gabriela Simesen de Bielke, Matías Oleastro, Néstor Pérez, Laura E. Pérez
Publikováno v:
Journal of Clinical Immunology. 32:1197-1203
Mutations in the Fas gene (TNFRSF6) are the most common causes of Autoimmune Lymphoproliferative Syndrome (ALPS-FAS). In Argentina almost a third of patients with ALPS-FAS present a missense mutation affecting the extracellular cysteine rich domain 2
Publikováno v:
Antiviral Therapy. 15:641-650
Background: Patterns and pathways of HIV type-1 (HIV-1) antiretroviral (ARV) drug resistance-associated mutations in clinical isolates are conditioned by ARV history and factors such as viral subtype and fitness. Our aim was to analyse the frequency
Autor:
Silvia Danielian, Jorge Rossi, Marta Zelazko, Matías Oleastro, Andrea Bernasconi, Natalia Basile, Emma Prieto, Paul A. Roche, Carlos Rocco, Darío Barsotti, Jorge Braier
Publikováno v:
J Clin Immunol
INTRODUCTION: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease with major diagnostic and therapeutic difficulties, basically comprising two different conditions: primary and secondary forms. Recent advances regarding molecular d
Autor:
Andrea Mangano, Luisa Sen, Cecilia Colombero, Gabriel Catano, Paula C. Aulicino, Rosa Bologna, Carlos Rocco, Debora Mecikovsky
Background: Lipoprotein lipase is a key enzyme in lipid metabolism, especially for plasma triglycerides (TGs). Genetic variants have been associated with lipid levels in healthy individuals, cardiovascular disease, obesity and diabetes. Our aim was t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38631c00a35ab6ad076e44d79f502436
https://insights.ovid.com/crossref?an=00006454-201502000-00009
https://insights.ovid.com/crossref?an=00006454-201502000-00009
Autor:
Natalia Perez Garrido, Carlos Rocco, Marta Ciaccio, Alicia Belgorosky, N Saraco, Marco Aurelio Rivarola, Mariana Costanzo, Pablo Ramirez, José García Feyling, Gladys Pena, Diana Monica Warman, Roxana Marino, Matias Juanes, Gabriela Guercio, Mirta Miras
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Context: Aromatase is the key enzyme for estrogen biosynthesis and is encoded by the CYP19A1 gene. Since 1991, several molecular CYP19A1 gene alterations associated with aromatase deficiency have been described in both sexes. Objective: The objective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::961ca4c0844f1ffa9d199efcfe40464a
https://academic.oup.com/jcem/article/100/2/E301/2814966
https://academic.oup.com/jcem/article/100/2/E301/2814966
Publikováno v:
Journal of the International AIDS Society
Introduction: HIV-1-associated CD4+ T-cell depletion is a consequence of uninfected cell death. Nef is one of the viral factors that trigger apoptosis on bystander cells, though the plasma Nef levels do not correlate with Th lymphocytes counts. The a
Publikováno v:
Journal of Virology. 81:427-429
The epidemic of human immunodeficiency virus type 1 (HIV-1) in Argentina is distinctive in that many infections are caused by subtype BF recombinant viruses. To determine their demographic history, we estimated the evolutionary rate, mode of populati
Publikováno v:
AIDS research and human retroviruses. 29(7)
Polymorphisms occurring at the p6gag protein of HIV-1 have been previously found to have an impact on viral fitness and antiretroviral (ARV) resistance, mainly on subtype B genomes. We compared p6gag variability in a large group of 165 subtype F gag-
Autor:
Soledad Hegoburu, Andrea Mangano, Carlos Rocco, Debora Mecikovsky, Paula C. Aulicino, Guillermo F. Bramuglia, Rosa Bologna, Luisa Sen, Verónica Curras, Carolina Paula Bellusci
Publikováno v:
Gene. 522(1)
Background: Variability in MDR1 and PXR has been associated with differences in drug plasma levels and response to antiretroviral therapy. We investigated whether polymorphisms in MDR1 (T-129C, C1236T and C3435T) and PXR (C63396T) affect lopinavir pl
Publikováno v:
AIDS Research and Human Retroviruses. 19:943-945